The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels

Completed · Phase 3

Conditions studied: Neonatal Abstinence Syndrome, Aromatherapy

In brief

Determine the effectiveness of lavender and chamomile aromatherapy of mitigation of symptoms of Neonatal Abstinence Syndrome

Key facts

Study ID

NCT03097484

Run by

John M. Daniel

People needed

38

Starts

2015-07-25

Expected to finish

2017-04-30

Last updated by the study team

2019-05-14

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Infants greater than or equal to 36 weeks EGA
• Intrauterine opioid exposure
• Primary diagnosis of NAS
• Parental permission to participate

You may not qualify if…

• Infants less than 36 weeks EGA
• Major congenital anomalies
• Latrogenic drug withdrawal
• Diagnosis of infection or respiratory distress
• Prior initiation of opioid replacement therapy
• Non-English speaking
• Infants with respiratory conditions

Where it is running

• University of Kentucky — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.